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Impairment of vascular regeneration precedes progressive glo- The regenerative potential of the glomerular archi-
merulosclerosis in anti-Thy 1 glomerulonephritis. tecture, particularly the glomerular microvasculature,
Background. It has been proposed that glomerular hemody- is regulated by complex pathways. Angiogenesis, repre-
namic changes or glomerular growth response may promote the
sented by the formation of new vessels from existingdevelopment of glomerulosclerosis, irrespective of its etiology.
vessels, plays an important role in tissue or organ repairFurther experimental models are needed to clarify the cellular
and molecular mechanisms that lead to progressive glomerulo- in some physiological and pathological conditions. Re-
sclerosis with an irreversible course. We designed a model of cent studies have revealed that glomerular capillary re-
irreversible glomerulosclerosis, using anti-Thy-1.1 injection fol- pair was induced in recovery models of glomerulonephri-
lowed by uninephrectomy, and examined the role of glomerular
tis, such as anti-Thy 1 glomerulonephritis (GN) [1] andendothelial cell responses in the process of progressive sclerotic
Habu snake venom induced glomerular injury [2]. John-changes.
son and colleagues showed that endothelial cell prolifer-Method. Rats were injected with anti-Thy-1.1 monoclonal
antibody, 1-22-3, and 30 minutes later, unilateral nephrectomy ation increased seven- to nine-fold during the first week
(one-kidney group) or sham operation (two-kidney group) was following glomerular injury with anti-Thy 1 antibody [1].
performed. Rats were sacrificed for histological examination Shimizu et al demonstrated that the development of glo-
on days 3, 14, 56, and 84 after injection. The density of the glo-
merular sclerotic lesions was associated with a loss ofmerular capillary tuft was assessed by immunofluorescent stain-
capillaries, resulting from accelerated apoptosis of glo-ing for endothelial specific antigens. The mRNA expression
merular endothelial cells [2–5]. However, the one-shotof intercellular adhesion molecule-1 (ICAM-1), vascular cell
adhesion molecule-1 (VCAM-1), platelet-endothelial cell adhe- anti-Thy 1 antibody model shows a fundamentally re-
sion molecule-1 (PECAM-1), and vascular endothelial growth versible course, without progressive glomerulosclerosis
factor (VEGF) also was followed up by reverse transcription- [6]. On the other hand, in the experimental model ofpolymerase chain reaction (RT-PCR).
the five-sixths nephrectomized rat, microvascular injuryResults. Semiquantitative analysis revealed that the capil-
may initiate the development and progression of glomer-lary density and mRNA expression of PECAM-1, VCAM-1
and VEGF were significantly lower in the one-kidney group ulosclerosis, as endothelial cells, particularly in the di-
compared to the two-kidney group on day 14. On day 84, lated capillaries at the vascular pole, express angioten-
progressive glomerulosclerotic lesions were found, followed by sinogen and transforming growth factor-beta (TGF-)
a decrease of the capillary density in the one-kidney group, mRNA as early as 24 days after ablation, a time whenwhile the glomerular architecture recovered to an almost nor-
sclerosis was not yet evident [7].mal state in the two-kidney group.
It has been proposed that glomerular hemodynamicConclusions. Progressive glomerulosclerosis can be induced
in the rat by a one shot injection of anti-Thy 1.1 monoclonal changes or glomerular growth response may promote
antibody followed by unilateral nephrectomy. This model shows the development of glomerulosclerosis, irrespective of
that there is a positive association between impairment of vas- etiology [7–11]. However, there are very few experimen-
cular regeneration and the development of glomerulosclerosis.
tal models of glomerulosclerosis, with the exception of
the ablation model. Further experimental models are
needed to clarify the cellular and molecular mechanismsKey words: uninephrectomy, sclerotic lesions, glomerular microvascu-
lature, angiogenesis, kidney repair, renal insufficiency, hemodynamics. leading to progressive glomerulosclerosis with an irre-
versible course. We have reported previously that pro-Received for publication February 12, 2001
gressive glomerulosclerosis developed within a relativelyand in revised form September 4, 2001
Accepted for publication September 9, 2001 short period (6 weeks) following administration of a sin-
gle injection of anti-Thy 1.1 antibody, named 1-22-3, to 2002 by the International Society of Nephrology
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unilaterally nephrectomized rats [12]. In this one-shot were sacrificed on day 84. To compare the profiles of
antibody model, the distorted glomerular structure was glomerular capillary repair, control rats without treat-
gradually reconstructed and most glomeruli regained an ment were sacrificed on days 3 and 84 (normal group).
almost normal structure, although the nephritogenicity
Serum biochemical analysisof the 1-22-3 antibody appeared to be stronger than
that of the commercially available anti-Thy 1.1 antibody, On day 84 the rats were killed and blood samples
OX-7 [13, 14]. From these earlier results, we could not were collected, and serum total protein as well as serum
definitely conclude that unilateral nephrectomy resulted concentrations of albumin, total cholesterol, creatinine
in progressive sclerosis, as rats were injected with a single and blood urea nitrogen (BUN) were measured.
dose of anti-Thy 1.1 antibody after unilateral nephrec-
tomy or sham operation. Under these conditions, much Urinalysis
more antibody was found in the remaining kidney, in On days 3, 14, 56, and 84 after the injection of antibody,
contrast to the situation in rats undergoing sham operation the rats were individually housed in metabolic cages with
(two kidneys) and injected with the same dose of antibody.
free access to water for collection of 24-hour urine speci-Our present study was undertaken to confirm the role
mens. The amount of urinary protein excreted was deter-of glomerular hyperfusion in the progression of glomeru-
mined by the Biuret method with bovine serum albuminlosclerosis induced by one shot of anti-Thy 1 antibody.
(BSA) as the standard [17].Furthermore, we sequentially examined glomerular cap-
illary repair, particularly the endothelial response, fol- Light microscopy
lowing diffuse mesangiolysis, which is representative of
Tissue for light microscopy was fixed in 10% neutral-the destruction of the glomerular network. For these
buffered formalin. The fixed material was cut at a thick-purposes, rats were injected with a single shot of anti-
ness of 4 m and stained with periodic acid-Schiff (PAS)Thy 1 antibody, followed by unilateral nephrectomy.
and periodic acid methenamine silver (PAM).This procedure ensured delivery of the same dose of
In the PAS-stained sections, mesangial proliferationnephritogenic antibody to the kidneys, because binding
and glomerular sclerosis were graded semiquantitativelyof anti-Thy 1 antibody to the glomerular mesangium
on a scale of 0 to 4, as reported previously [18].reached a plateau level within the short period of 30
minutes [15]. Our results showed that there was a marked
Immunofluorescent microscopy and analysis ofdifference in the formation of progressive glomeruloscle-
capillary densityrosis, laboratory findings in blood and urinalysis, as well
as regeneration of glomerular endothelial cells between To assess regeneration of glomerular capillaries and
the uninephrectomized (one-kidney) and sham-operated to prevent nonspecific and/or indefinite positive staining,
(two-kidney) groups in the model employed. the number of microvasculatures were counted after im-
munofluorescent staining for platelet-endothelial cell ad-
hesion molecule-1 (PECAM-1; CD31) and rat endothe-METHODS
lial cell antigen (RECA-1). Indirect immunofluorescenceAnimals
was performed on 4-m frozen sections as described
Young male Wistar rats, four to five weeks old, weigh- elsewhere [14]. The primary antibodies were monoclonal
ing 100 g (Charles River Japan, Yokohama, Kanagawa, mouse anti-rat CD31 (Serotec Ltd., Kindlington, UK) and
Japan) were used. anti-rat RECA-1 (monoclonal mouse anti-rat RECA-1;
Serotec). The secondary antibody was FITC-conjugatedExperimental protocol
goat anti-mouse IgG2a (Southern Biotechnology, Bir-
The nephritogenic anti-Thy 1.1 monoclonal antibody,
mingham, AL, USA).1-22-3, was produced in mice immunized with rat glomer-
Glomerular capillaries, identified by positive staininguli as described previously [16]. For the induction of
for PECAM-1 and RECA-1, were counted under a fluo-anti-Thy 1.1 nephritis, rats were injected intravenously
rescence microscope to determine the capillary density.with 0.5 mg of 1-22-3, and then 30 minutes after injection,
Photographs of immunofluorescence-stained glomeruliunilateral nephrectomy of the left kidney was performed
(magnification 400) were digitalized into 327  460(one-kidney group). As the control group, a sham opera-
pixel color scale images by the Nikon scan vergion 5.3Jtion was performed after injection with the same dose
program, and the glomerular area was measured usingof antibody (two-kidney group), and unilateral nephrec-
the public domain NIH image 1.59 program. A total of 20tomy was done without anti-Thy 1.1 antibody injection
glomeruli from three rats in each group were randomly(Nx group). Rats were sacrificed on days 3, 14, 56 and
selected, and the capillary density was normalized to the84 after the administration of 1-22-3 in the one-kidney
and two-kidney groups. The rats from the Nx group number of capillaries per square millimeter.
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Table 1. Primer list of RT-PCR
Upper primer Lower primer Fragment size
GAPDH 5-TCCCTCAAGATTGTCAGCAA-3 5-AGATCCACAACGGATACATT-3 309
ICAM-1 5-CTGGAGAGCACAAACAGCAGAG-3 5-AAGGCCGCAGAGCAAAAGAAGC-3 385
VCAM-1 5-TAAGTTACACAGCAGTCAAATGGA-3 5-CACATACATAAATGCCGGAATCTT-3 283
PECAM-1 5-AGGGCTCATTGCGGTGGTTGTCAT-3 5-TAAGGGAGCCTTCCGTTCTAGAGT-3 348,404
VEGF 5-AACCATGAACTTTCTGCTCTCTTG-3 5-GCCTGGCTCACCGCCTTGGCTTGTC-3 360,492,564
Abbreviations are: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ICAM-1, intercellular cell adhesion molecule; VCAM-1, vascular cell adhesion molecule-1;
PECAM-1, platelet-endothelial cell adhesion molecule-1; VEGF, vascular endothelial growth factor.
Table 2. Urinary protein excretion (mg/day)Semiquantitative RT-PCR
DayIsolated glomeruli were obtained from rat kidneys by
Group (N10) 3 14 56 84the sequential sieving technique [19]. PolyA RNA was
extracted from the glomeruli by an acid-guanidinium-thio- One-kidney 46.529.8 20.915.9 65.7125.5 294.093.8a
Two-kidney 122.478.8 45.040.9 28.971.8 54.255.8cyanate-phenol-chloroform method [20], using RNA
Nx 42.574.5STAT-60 (TEL-TEST “B”, Inc., Friendswood, TX,
Each value is expressed as mean  SD.USA) and the QuickPrep Micro mRNA Purification Kit
a P  0.001 vs. both two-kidney group and Nx group (Student t test)
(Pharmacia Biotech Inc., Piscataway, NJ, USA).
Reverse transcription (RT) was performed with 0.1 m
of polyA RNA as a template, using the T Primed First-
Strand Kit (Pharmacia Biotech). The cDNAs were amp- Statistical analysis
lified by PCR with the primers listed in Table 1. The Data are expressed as mean  SD. Statistical signifi-
primers for glyceraldehyde-3-phosphate dehydrogen- cance was evaluated by the Student t test or Mann-Whit-
ase (GAPDH) and intercellular adhesion molecule-1 ney U test. A value of P  0.05 was taken to denote
(ICAM-1) were used as described previously [21]. The statistical significance.
primer for vascular-endothelial growth factor (VEGF)
was a gift from Dr. Masahiro Maeda (IBL Inc., Fujioka,
RESULTSGunma, Japan). The primers for vascular cell adhesion
molecule-1 (VCAM-1) were designed according to the Urinary protein excretion
GenBank database (National Center for Biotechnology
Urinary protein excretion was determined on days 3,Information, National Institutes of Health, Bethesda,
14, 56, and 84 (Table 2). In the two-kidney group, inMD, USA). The primer for rat PECAM-1 was constructed
which rats were injected with anti-Thy 1.1 antibody andbased on published human and mouse PECAM-1 nucle-
did not undergo unilateral nephrectomy, the maximumotide sequences. We obtained two different bands from
urinary protein excretion was 122.4  24.9 mg/24 h onRT-polymerase chain reaction (RT-PCR), which corre-
day 3, which then decreased to 45.0  13.0 mg/24 h onsponded to the splice variants. Their identity was verified
day 14, and 28.9  22.7 mg/24 h on day 56. In the one-by sequence analysis. In this experiment, the band inten-
kidney group, in which rats were injected with 1-22-3sities of two splice variants behaved in the same manner.
antibody followed by unilateral nephrectomy, urinaryAll PCRs were performed with 100 L of a mixture
protein excretion was 46.5  9.4 mg/24 h on day 3 andcontaining Gene Taq (Wako/NIPPON GENE, Osaka,
decreased to 20.9  5.0 mg/24 h on day 14. However, itJapan) as follows: after initial denaturation for five min-
rose again to 65.7 mg/24 h on day 56, and was 294 utes at 94 	C, 30 cycles of amplification were carried out.
29.7 mg/24 h on day 84, significantly higher than in theEach sample was incubated in a DNA thermal cycler
two-kidney group (54.2  17.7 mg/24 h) and the Nx(PC800; ASTEC, Fukuoka, Japan) at 50	 to 60	, using
group (42.5  23.6 mg/24 h).the primer indicated in Table 1. The PCR products were
separated by electrophoresis in 2% agarose gels and
Serum biochemical analysis on day 84 afterstained with ethidium bromide. The intensities of the
disease inductioncDNA bands were analyzed by scanning densitometry
Results of biochemical analysis on day 84, the end ofusing Multi-Analyst/Macintosh Version 1.0 (Bio-Rad
the course examined, are summarized in Table 3. SerumLaboratories, Hercules, CA, USA). The band intensities
total protein and serum concentration of albumin werewere normalized to the GAPDH band intensities and
significantly lower, and serum total cholesterol, creati-the results expressed as ratios. For each group and glo-
nine, and BUN values were significantly higher in themerular extract, PCR data were obtained from four ex-
periments with the same schedule. one-kidney group than the two-kidney and Nx groups.
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Table 3. Serum biochemical analysis on day 84 after disease induction
TP Alb TC BUN Cr
g/dL mg/dL
One-kidney 6.080.26a 3.540.16a 126.834.3a 35.910.9a 0.470.16a
Two-kidney 6.890.49 3.990.40 80.217.3 21.14.8 0.300.05
Nx 6.750.35 4.000.36 80.618.6 21.82.6 0.290.03
Each value is expressed as mean  SD; N  10. Abbreviations are: TP; total protein; Alb, albumin; TC, total cholesterol; BUN, blood urea nitrogen; Cr, creatinine.
a P  0.001 vs. both two-kidney group and Nx group (Student t test)
Fig. 1. Light microscopic findings in the glo-
meruli on days 3, 14, and 56 after anti-Thy 1
antibody injection in the two-kidney group
(A, C, E ) and the one-kidney group (B, D,
F ). (A, B) Diffuse mesangiolytic changes were
found on day 3 in both groups. Some glomeruli
showed microaneurysmal ballooning. (C, D)
There was diffuse mesangial cell proliferation
and mesangial matrix expansion on day 14 in
both groups. (E, F) Mesangial cell prolifera-
tion decreased by day 56 in the two-kidney
group (E); however, mesangial proliferation in
a focal, segmental pattern was often observed
in the one-kidney group (F) (PAS stain,400).
Light microscopy ular sclerosis index (Figs. 3 and 4). By day 56 the mesan-
gial cell proliferation was remarkably decreased (Fig. 1Glomerular alterations were examined on days 3, 14,
E, F). Although there was no significant difference in56, and 84 after anti-Thy 1 antibody injection by light
mesangial proliferation or glomerular sclerosis index be-microscopy. As reported previously [6], diffuse mesangi-
tween the one-kidney and two-kidney groups, mesangialolytic changes were found on day 3 in both one-kidney
proliferation in a focal, segmental pattern was often ob-and two-kidney groups. Some glomeruli showed mi-
served in the one-kidney group.croaneurysmal ballooning (Fig. 1 A, B). On day 14, there
On the last day of the study period, day 84, there waswas diffuse mesangial cell proliferation and mesangial
a sharp contrast in the histological changes seen betweenmatrix expansion in both groups (Fig. 1 C, D), which
showed the same degree of cell proliferation and glomer- these two groups (Fig. 2). Mesangial proliferative changes,
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Fig. 2. Light microscopic findings of the kid-
ney on day 84. Mesangial proliferative changes,
which appeared to be recovering by day 56,
subsequently deteriorated in the one-kidney
group (C, D). Glomerular hypertrophy was
evident and diffuse, severe mesangial cell pro-
liferation with matrix expansion was observed
in the majority of the glomeruli. Tubular atro-
phic changes with interstitial cell infiltration
were also found diffusely (D). Only mild mes-
angial proliferative changes were observed in
the two-kidney group (A, B) (PAS stain; A,
C 50; B, D 400).
Fig. 3. Mesangial proliferation index in the () one-kidney and () Fig. 4. Glomerular sclerosis index in the () one-kidney and () two-
two-kidney groups. Each column represents the mean  SD of five kidney groups. Each column represents the mean  SD of five rats.
rats. The level of mesangial proliferation was significantly enhanced on The grade of glomerular sclerosis had progressed on day 84 in the one-
day 84 in the one-kidney group (Mann-Whitney U test; *P  0.01). kidney group (Mann-Whitney U test).
which had decreased by day 56, subsequently worsened filtration were found. Only mild mesangial proliferative
in the one-kidney group. Glomerular hypertrophy was changes were observed in the two-kidney group, and no
evident and diffuse, severe mesangial cell proliferation pathological findings were observed on day 84 in the Nx
with matrix expansion was observed in the majority of group (not shown).
the glomeruli. The mesangial proliferation index was
Glomerular capillary regenerationsignificantly higher than in the two-kidney group (Figs. 3
and 4). Some glomeruli showed crescentic lesions, and To analyze glomerular capillary regeneration, we used
PECAM-1 and RECA-1 as markers for endothelial cells.diffuse tubular atrophic changes with interstitial cell in-
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As shown in Figures 5 and 6B, the number of RECA-1– one-kidney group, although the mesangial proliferative
changes appeared to be indistinguishable from that ofpositive capillaries decreased significantly on day 3 in
both one-kidney and two-kidney groups. The capillary the two-kidney group by light microscopy. By day 84,
rats from the one-kidney group revealed a quite differentdensity was significantly lower on day 14 in the one-
kidney group than in the two-kidney group. In the two- outcome: progressive glomerulosclerosis with impaired
renal function.kidney model, the capillary density had recovered to
normal by day 14. While the number of capillaries ap- Glomerular microaneurysm formation in humans has
been observed after poisoning with snake venoms, systemicpeared to increase in the one-kidney model by day 56,
they had not recovered completely by day 84, and were hypertension, and in some types of glomerulonephri-
tides, including diabetic nephropathy [22]. Experimen-significantly lower than in the two-kidney and normal
control groups. Similar results were observed with re- tally, complement-dependent mesangial injury induced
by anti-Thy 1.1 antibody produced mesangiolysis, lead-spect to the PECAM-1–positive capillaries (Fig. 6A).
ing to capillary ballooning and formation of microaneur-
Semiquantitative RT-PCR ysms [6]. Johnson and colleagues have extensively exam-
ined process from the destruction of the glomerularmRNA expressions for ICAM-1, VCAM-1, and PECAM-1.
To follow up the expression of endothelial cell markers microvasculature to the resolution phase, in which the
glomeruli spontaneously recover [1, 23, 24]. These au-at the mRNA levels semiquantitatively, we examined
ICAM-1, VCAM-1, and PECAM-1. The band intensities thors suggest that neovacularization due to a marked
endothelial cell proliferative response can occur alongfor PECAM-1 were expressed as the total sum of two
splice variants. Figure 7 shows a tendency for the expres- with proliferation and migration of mesangial cells. Their
theory and the results from our study allow us to hypoth-sion of mRNA for ICAM-1 to be increased on day 3,
which returned to control levels by day 14. However, esize that the deteriorated glomerular tufts, resulting
from anti-Thy 1.1 antibody-induced mesangial injury, aremRNA expression appeared to be increased again on
able to return to normal if there is a balance betweendays 56 to 84 in the one-kidney group.
cell proliferation and apoptosis, where capillary repairThe expression patterns of mRNA for VCAM-1 and
is done by angiogenesis, and the mesangium is remodeledPECAM-1 changed similarly. In the one-kidney group,
by mesangial cell proliferation and migration in combi-mRNA expression was reduced to significantly lower lev-
nation with mesangial matrix turnover [23, 24].els by day 14 compared to the two-kidney group, and
Our current study shows that while acute mesangialreturned to normal levels by day 56, but by day 84 reached
cell injury with microaneurysms could be induced in ahigher levels than in the two-kidney group.
similar pattern in both the one- and two-kidney groups,mRNA expression for VEGF. To examine the effects
progressive glomerulosclerosis with impaired renal func-of angiogenic factor in this experimental model, VEGF
tion only developed within three months in the one-kidneymRNA expression was investigated. Three splice variants
group. This strongly suggests that glomerular hyperfu-were found in the RT-PCR. These three splice variants
sion induced by unilateral nephrectomy may promotemoved in a similar manner, and the band intensities were
the development of glomerulosclerosis. At 14 days afterexpressed as the total for these three bands. The mRNA
disease induction, urinary protein excretion decreasedexpression was significantly decreased by day 14 in the
and mesangioproliferative changes in both groups wereone-kidney group compared to the two-kidney group.
indistinguishable, although endothelial cell markers were
already suppressed at the protein and mRNA levels, with
DISCUSSION a remarkable decrease in the number of capillaries in
The present study shows that progressive glomerulo- glomeruli of the one-kidney group. With time, regenera-
sclerosis leading to renal insufficiency could be induced tion of the glomerular capillary progressed, and they
in the rat by a one shot injection of anti-Thy 1.1 mono- finally returned to normal in the two-kidney group by
clonal antibody followed by unilateral nephrectomy. In 56 days after disease induction. In the one-kidney group,
contrast, a one shot injection of anti-Thy 1.1 antibody however, the number of capillaries that appeared to re-
without unilateral nephrectomy led to recovery to nor- cover by 56 days then decreased remarkably, which led
mal after the induction of acute, mesangiolytic and then to diffuse glomerulosclerosis with massive proteinuria at
mesangioproliferative glomerulonephritis [6]. At 3 days 84 days, while expression of endothelial cell markers
after antibody injection, there were no apparent differ- at the mRNA level had increased. During the period
ences in the destructive changes in glomerular tufts be- between day 14 and day 56, regeneration of glomerular
tween the uninephrectomized (one-kidney group) and endothelial cells in the one-kidney group was presum-
sham operated (two-kidney group) rats. At 14 days, im- ably quite different from that in the two-kidney group,
munofluorescent and RT-PCR studies showed suppres- the reversible model.
There is increasing evidence that glomerular hyperten-sion of regeneration of glomerular endothelial cells in the
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Fig. 5. Immunofluorescent analysis of rat endothelial cell antigen (RECA-1) in the two-kidney group (A, C, E, G ) and the one-kidney group (B,
D, F, H ). (A, B) Three days after injection. RECA-1–positive capillaries were dilated, and microaneurysmal ballooning was found in some
glomeruli in both groups. (C, D) On day 14, RECA-1–positive endothelial cells were found on the periphery of the glomeruli in the one-kidney
group (D). (E, F) On day 56, a RECA-1–positive capillary network developed in both groups. (G, H) On day 84, the number of RECA-1–positive
capillaries was remarkably decreased and dilated capillaries were now detected in the one-kidney group (400).
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lesions in the remaining kidney [28]. Nagata, Scharer
and Kriz reported that uninephrectomy at ten days after
birth resulted in glomerular hypertrophy and glomerular
capillary dilatation by 24 weeks after surgery [29]. How-
ever, our preliminary study revealed that there were no
pathologic changes by light microscopy in the remaining
kidney at 12 weeks after the only treatment of uni-
nephrectomy at 4 weeks of age (data not shown). Thus,
the age of the animal when uninephrectomy is performed
may be critical to determine the subsequent glomerular
injury.
Glomerular visceral epithelial cells are known to be
a cellular source of VEGF [30], which plays an important
role in angiogenic regeneration. Ostendorf et al have
demonstrated that administration of the VEGF antago-
nist, VEGF165 aptamer coupled to polyethylene glycol,
led to a reduction of glomerular endothelial regeneration
and an exacerbation of capillary damage in anti-Thy 1
GN [31]. The present study found that glomerular VEGF
mRNA expression in the one-kidney group was signifi-
cantly suppressed on day 14. Impairment of vascular re-
generation resulting in a remarkable decrease in capil-
lary density may be explained by suppressed synthesis
of VEGF, probably resulting from visceral epithelial cell
injury, although the major cell source of VEGF has not
been identified in our models.
Fig. 6. Glomerular capillary repair. Glomerular capillary regeneration It is worthwhile to discuss the distinctly different
was evaluated during the disease course by immunofluorescent staining patterns of glomerular capillary repair seen in the two-
of endothelial cell markers. (A) Platelet-endothelial cell adhesion mole-
kidney and one-kidney groups, which finally led to acule-1 (PECAM-1)–positive capillaries. The capillary density was ex-
pressed as the number of PECAM-1–positive capillaries per m2 (Stu- remarkable decrease in capillary density and diffuse glo-
dent t test; N  3; *P  0.001). (B) Rat endothelial cell antigen-1 merulosclerosis in the one-kidney model. In the one-
(RECA-1)–positive capillaries. The capillary density was expressed as
kidney model, capillary density appeared to increase bythe number of RECA-1 positive capillaries per m2 (Student t test;
N  3; *P  0.001). Symbols are: () one-kidney group; ( ) two- day 56, but did not recover completely to a normal den-
kidney group; () controls. sity on day 84. Assuming that there is a process of glomer-
ular repair in the one-shot reversible model of ATS, the
return to normal architecture of the glomerular capillary
tuft may need a well-balanced recruitment of mesangialsion is a pivotal factor in the initiation and progression
of glomerular injury [11]. Micropuncture studies have and endothelial cells, and production of extracellular
matrix. This regenerative process of glomerular capillaryrevealed that glomerular capillary hydraulic pressure
and the glomerular transcapillary pressure difference are tufts might be impaired in the one-kidney model during
the chronic course from day 14 to day 84, leading toincreased significantly after uninephrectomy [25, 26]. A
rise in glomerular capillary hydraulic pressure produces progressive glomerulosclerosis. In vitro studies, includ-
ing ours [32–36] have shown that mesangial cell behavioran increase in capillary wall tension, resulting in stretch-
ing of the glomerular capillary wall. Mechanical stretch- is regulated by intercellular contact with endothelial
cells, and by the surrounding extracellular matrix constit-ing stimulates endothelial expression of cell adhesion
molecules in inflammatory cells [27], and induces the uents. In the absence of contact with endothelial cells
or normal components of the extracellular matrix, mes-production of vasoactive substances and cytokines such
as angiotensinogen and TGF- from injured or activated angial cells showed a pathologic nature, manifested as
increased proliferative activity and production of inter-endothelium, which may exacerbate glomerular inflam-
mation and lead to progressive glomerulosclerosis [7]. stitial collagen, which is often used as a marker of pro-
gressive glomerulosclerosis. Recently, we have examinedMorphological examination of the glomeruli from rats
with extensive renal ablation confirms endothelial and glomerular hemodynamic changes in the acute phase of
the ATS model, to confirm the functional recovery ofepithelial cell injury and structural alteration [8], while
unilateral nephrectomy induces an acute increase in he- the microvasculature by using a confocal laser scanning
microscope. Destructive changes of the glomerular capil-modynamic function followed by no apparent glomerular
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Fig. 7. Reverse transcription-polymerase chain
reaction (RT-PCR) analysis of endothelial
cell markers and vascular endothelial growth
factor (VEGF). (A) mRNA for GAPDH. Ex-
pression of mRNA encoding ICAM-1 (B),
VCAM-1 (C ), and PECAM-1 (D) as endothe-
lial cell markers (N  5). Symbols are: ()
control; ( ) one-kidney; () two-kidney; ( )
unilateral nephrectomy without anti-Thy 1,1
antibody injection (Nx). The mRNA expres-
sion for ICAM-1 was increased on day 3 and
returned to control levels on day 14. The
mRNA expression for VCAM-1 and PE-
CAM-1 in the one-kidney group were reduced
significantly on day 14, and raised on day 84,
compared to the two-kidney group (P  0.05,
Student t test). (E ) Expression of mRNA en-
coding VEGF (N 5). The mRNA expression
for VEGF in the one-kidney group was sig-
nificantly decreased on day 14 compared to
the two-kidney group (*P  0.05, Student t
test). The band intensities were normalized
to the GAPDH band intensities (A) and the
results were expressed as ratios.
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Fig. 7. (Continued)
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experimental proliferative glomerulonephritis. Nephron 79:206–lary during mesangiolysis were followed by regeneration,
214, 1998
including endothelial cell proliferation and capillary for- 4. Kitamura H, Shimizu A, Masuda Y, et al: Apoptosis in glomerular
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